Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
Journal of Labelled Compounds & Radiopharmaceuticals|November 15, 2024
A Brief Review of Radiolabelling Nucleic Acid-Based Molecules for Tracking and MonitoringMartin R Edelmann, Filippo Sladojevich, Stephen M Husbands, et al.Behavioural Pharmacology|November 16, 2005
Effects of the long-lasting kappa opioid 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl) ethyl] acetamide in a drug discrimination and warm water tail-withdrawal procedureJolan M Terner, Lisa M Lomas, John W Lewis, et al.Journal of Psychopharmacology (Oxford, England)|November 3, 2012
In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptorJoseph J Casal-Dominguez, Mary Clark, John R Traynor, et al.Neuroscience Letters|July 3, 2007
The effect of 1-(4,5-dihydro-1H-imidazol-2-yl) isoquinoline on monoamine release and turnover in the rat frontal cortexHaya Abu Ghazaleh, Maggie D Lalies, Stephen M Husbands, et al.Psychopharmacology|September 23, 2008
The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in ratsMikhail N Koffarnus, Benjamin Greedy, Stephen M Husbands, et al.Molecular Pharmaceutics|May 10, 2019
Simultaneous Transdermal Delivery of Buprenorphine Hydrochloride and Naltrexone Hydrochloride by IontophoresisSarah F Cordery, Stephen M Husbands, Christopher P Bailey, et al.The Journal of Pharmacology and Experimental Therapeutics|December 24, 2010
The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced rewardTaline V Khroyan, Willma E Polgar, Gerta Cami-Kobeci, et al.The Journal of Pharmacology and Experimental Therapeutics|November 23, 2018
Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus MonkeysLisa R Gerak, David R Maguire, James H Woods, et al.The Journal of Pharmacology and Experimental Therapeutics|November 8, 2018
Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus MonkeysDavid R Maguire, Lisa R Gerak, James H Woods, et al.Drug and Alcohol Dependence|December 3, 2019
The development and validation of a human screening model of tobacco abstinenceMeryem Grabski, H Valerie Curran, David J Nutt, et al.Pageof 11